These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27339420)

  • 1. Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor.
    Chen H; Wang Y; Wang T; Shi D; Sun Z; Xia C; Wang B
    J Nanobiotechnology; 2016 Jun; 14(1):52. PubMed ID: 27339420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile Synthesis of Gd-Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging.
    Yang W; Guo W; Gong X; Zhang B; Wang S; Chen N; Yang W; Tu Y; Fang X; Chang J
    ACS Appl Mater Interfaces; 2015 Aug; 7(33):18759-68. PubMed ID: 26257133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging.
    Li J; You J; Dai Y; Shi M; Han C; Xu K
    Anal Chem; 2014 Nov; 86(22):11306-11. PubMed ID: 25338209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
    Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiresponsive Nanoprobes for Turn-On Fluorescence/
    Li Y; Zhang H; Guo C; Hu G; Wang L
    Anal Chem; 2020 Sep; 92(17):11739-11746. PubMed ID: 32786481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomedical Applications of Fluorescent and Magnetic Resonance Imaging Dual-Modality Probes.
    Deng Y; Xu A; Yu Y; Fu C; Liang G
    Chembiochem; 2019 Feb; 20(4):499-510. PubMed ID: 30182382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer.
    Yuan JP; Wang LW; Qu AP; Chen JM; Xiang QM; Chen C; Sun SR; Pang DW; Liu J; Li Y
    PLoS One; 2015; 10(4):e0122734. PubMed ID: 25856425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile preparation of rare-earth based fluorescence/MRI dual-modal nanoprobe for targeted cancer cell imaging.
    Huang S; Chen P; Xu C
    Talanta; 2017 Apr; 165():161-166. PubMed ID: 28153236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbium-doped gadolinium oxide nanoparticles prepared by laser ablation in liquid for use as a fluorescence and magnetic resonance imaging dual-modal contrast agent.
    Chen F; Chen M; Yang C; Liu J; Luo N; Yang G; Chen D; Li L
    Phys Chem Chem Phys; 2015 Jan; 17(2):1189-96. PubMed ID: 25418675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Glutathione Activatable Nanoprobes for Fluorescence and
    Zhang Y; Ma Q; Yan Y; Guo C; Xu S; Wang L
    Anal Chem; 2020 Dec; 92(23):15679-15684. PubMed ID: 33174733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas.
    Irini T; Paraskevi A; Ioanna G; Christos P; Lydia N
    APMIS; 2013 Sep; 121(9):797-805. PubMed ID: 23278310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.
    Barnes SL; Sorace AG; Loveless ME; Whisenant JG; Yankeelov TE
    NMR Biomed; 2015 Oct; 28(10):1345-56. PubMed ID: 26332194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional iron oxide-carbon hybrid nanoparticles for targeted fluorescent/MR dual-modal imaging and detection of breast cancer cells.
    Han C; Zhang A; Kong Y; Yu N; Xie T; Dou B; Li K; Wang Y; Li J; Xu K
    Anal Chim Acta; 2019 Aug; 1067():115-128. PubMed ID: 31047143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual in vivo photoacoustic and fluorescence imaging of HER2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance.
    Maeda A; Bu J; Chen J; Zheng G; DaCosta RS
    Mol Imaging; 2014; 13():. PubMed ID: 25430722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives.
    Wang LW; Peng CW; Chen C; Li Y
    Breast Cancer Res Treat; 2015 May; 151(1):7-17. PubMed ID: 25833213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging.
    Liu Y; Ai K; Yuan Q; Lu L
    Biomaterials; 2011 Feb; 32(4):1185-92. PubMed ID: 21055806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer.
    Xiang QM; Wang LW; Yuan JP; Chen JM; Yang F; Li Y
    Exp Mol Pathol; 2015 Aug; 99(1):133-8. PubMed ID: 26102249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon quantum dot stabilized gadolinium nanoprobe prepared via a one-pot hydrothermal approach for magnetic resonance and fluorescence dual-modality bioimaging.
    Xu Y; Jia XH; Yin XB; He XW; Zhang YK
    Anal Chem; 2014 Dec; 86(24):12122-9. PubMed ID: 25383762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent activatable gadofullerene nanoprobes as NIR-MR dual-modal in vivo imaging contrast agent.
    Li C; Huang H; Cui R; Li J; Guo X; Yao H; Liu B; Xu B; Li Y; Liu S; Dong J; Xing G; Sun B
    Colloids Surf B Biointerfaces; 2018 Nov; 171():159-166. PubMed ID: 30029098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.